Cargando…
Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
Non-small cell lung cancer is one leading cause of death worldwide, and patients would greatly benefit from an early diagnosis. Since targeted and immunotherapies have emerged as novel approaches for more tailored treatments, repeated assessments of the tumor biology have become pivotal to drive cli...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017364/ https://www.ncbi.nlm.nih.gov/pubmed/31861557 http://dx.doi.org/10.3390/cancers12010017 |